Page last updated: 2024-09-05

sb 203580 and nu 7441

sb 203580 has been researched along with nu 7441 in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(nu 7441)
Trials
(nu 7441)
Recent Studies (post-2010) (nu 7441)
3,48941,13793082

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)nu 7441 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.03
Bromodomain-containing protein 4Homo sapiens (human)1
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)0.03
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)0.03
Type-1 angiotensin II receptorOryctolagus cuniculus (rabbit)0.13
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)1.7533
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.016
Serine/threonine-protein kinase mTORHomo sapiens (human)2.05
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.22
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)0.0242
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.03
Bromodomain testis-specific proteinHomo sapiens (human)3.5

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Munoz, L1

Reviews

1 review(s) available for sb 203580 and nu 7441

ArticleYear
Non-kinase targets of protein kinase inhibitors.
    Nature reviews. Drug discovery, 2017, Volume: 16, Issue:6

    Topics: Animals; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Kinases

2017

Other Studies

1 other study(ies) available for sb 203580 and nu 7441

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013